Form 4: Envoy Medical Director Amends Warrants, Extends Expiration

Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc., amended several warrants, replacing existing ones with new warrants extending their expiration dates to December 31, 2028.

Summary

• Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc. (COCH), reported changes in beneficial ownership.
• The report details the amendment of several outstanding warrants on September 4, 2025, replacing them with new warrants.
• These new warrants generally extend the expiration dates from various earlier dates (e.g., 02/27/2026, 08/27/2026, 03/11/2028, 06/26/2027) to a new common expiration date of December 31, 2028.
• The total number of Class A Common Stock beneficially owned by Mr. Taylor following these transactions is 2,953,607 directly, 2,526,058 indirectly through Taylor Sports Group, and 4,810,384 indirectly through GAT Funding, LLC.
• Additionally, GAT Funding, LLC indirectly holds Series A Preferred Stock convertible into 869,565 Class A Common Stock and warrants to purchase a total of 3,500,000 Class A Common Stock at various exercise prices ranging from $1.24 to $3.04.

Sentiment

Score: 5

Explanation: Neutral, as this filing reports a technical adjustment to existing insider holdings (warrant amendments) rather than a new investment or divestment, which typically does not signal a strong positive or negative outlook.

Positives

• The extension of warrant expiration dates to December 31, 2028, provides the holder, Glen A. Taylor, with a longer period to exercise these options, potentially allowing for more favorable market conditions.
• The amendments consolidate various warrant expiration dates into a single, later date, simplifying the management of these derivative securities.

Risks

• The existence of warrants to purchase 3,500,000 Class A Common Stock represents potential future dilution for existing shareholders if these warrants are exercised.
• The reported transaction date of September 4, 2025, is in the future, which is unusual for a Form 4 filing that typically reports past transactions. This could indicate a clerical error or a pre-planned future event.

Future Outlook

The extension of warrant expiration dates to December 31, 2028, provides a longer window for Glen A. Taylor to potentially exercise these derivative securities, which could lead to future share issuance.

Industry Context

Form 4 filings are standard regulatory disclosures for insider transactions. While warrant amendments are not daily occurrences, they are a known mechanism for insiders to adjust their equity positions and investment horizons within a company.

Related Party Transactions

• Glen A. Taylor is the owner and chairman of Taylor Sports Group, through which he indirectly holds Class A Common Stock.
• GAT Funding, LLC is an entity controlled by Glen A. Taylor, through which he indirectly holds Class A Common Stock, Series A Preferred Stock, and various warrants.

Stakeholder Impact

• Shareholders: Potential future dilution if the warrants are exercised, as new shares would be issued. The extension of warrant terms provides a longer period for this potential dilution to occur.

Next Steps

• Potential future exercise of the amended warrants by Glen A. Taylor or GAT Funding, LLC, prior to their new expiration date of December 31, 2028.

Key Dates

Recommendation

The filing details warrant amendments by a significant insider, extending their exercise period. This is a technical adjustment to existing holdings rather than a new investment or divestment, thus not warranting a change in investment thesis based solely on this report.

Keywords

Envoy Medical, COCH, Glen A. Taylor, Form 4, Insider Transaction, Beneficial Ownership, Warrants, Director, 10% Owner, Equity